HR
Howe & Rusling Portfolio holdings
AUM
$1.35B
This Quarter Return
+1.82%
1 Year Return
+20.22%
3 Year Return
+65.82%
5 Year Return
+120.71%
10 Year Return
+233.38%
AUM
$1.16B
AUM Growth
+$1.16B
(-0.25%)
Cap. Flow
-$6.64M
Cap. Flow
% of AUM
-0.57%
Top 10 Holdings %
Top 10 Hldgs %
33.01%
Holding
471
New
60
Increased
149
Reduced
138
Closed
61
Top Buys
| 1 |
McDonald's
MCD
|
$8.12M |
| 2 |
Danaher
DHR
|
$3.52M |
| 3 |
Idexx Laboratories
IDXX
|
$2.87M |
| 4 |
AstraZeneca
AZN
|
$2.4M |
| 5 |
AbbVie
ABBV
|
$1.84M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$7.87M |
| 2 |
Baxter International
BAX
|
$6.62M |
| 3 |
Monster Beverage
MNST
|
$4.08M |
| 4 |
McKesson
MCK
|
$3.99M |
| 5 |
Strategy Inc Common Stock Class A
MSTR
|
$2.59M |
Sector Composition
| 1 | Technology | 19.9% |
| 2 | Financials | 11.54% |
| 3 | Healthcare | 7.72% |
| 4 | Consumer Discretionary | 7.13% |
| 5 | Consumer Staples | 6.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vertex Pharmaceuticals
VRTX
$102B
| $3.58M | 0.31% |
8,894
-198
| -2% | -$79.7K |
|
77
Accenture
ACN
$158B
| $3.56M | 0.31% |
10,130
-312
| -3% | -$110K |
|
|
78
Danaher
DHR
$143B
| $3.52M | 0.3% |
+15,329
| New | +$3.52M |
|
79
ASML
ASML
$290B
| $3.51M | 0.3% |
5,067
-196
| -4% | -$136K |
|
|
80
Johnson & Johnson
JNJ
$429B
| $3.46M | 0.3% |
23,941
-54,388
| -69% | -$7.87M |
|
81
RTX Corp
RTX
$212B
| $2.99M | 0.26% |
25,835
+643
| +3% | +$74.4K |
|
82
iShares Core Dividend Growth ETF
DGRO
$33.5B
| $2.96M | 0.26% |
48,265
-3,587
| -7% | -$220K |
|
|
83
Idexx Laboratories
IDXX
$50.7B
| $2.87M | 0.25% |
+6,931
| New | +$2.87M |
|
84
Applied Materials
AMAT
$124B
| $2.84M | 0.25% |
17,476
+632
| +4% | +$103K |
|
85
Allient
ALNT
$757M
| $2.74M | 0.24% |
112,962
-8,014
| -7% | -$195K |
|
86
iShares Core MSCI EAFE ETF
IEFA
$149B
| $2.68M | 0.23% |
38,096
+506
| +1% | +$35.6K |
|
87
iShares MSCI Intl Quality Factor ETF
IQLT
$12.7B
| $2.65M | 0.23% |
71,378
-10,319
| -13% | -$383K |
|
88
BioMarin Pharmaceuticals
BMRN
$11.3B
| $2.59M | 0.22% |
39,355
-10,297
| -21% | -$677K |
|
89
Vanguard FTSE All-World ex-US ETF
VEU
$48.3B
| $2.54M | 0.22% |
44,255
-427
| -1% | -$24.5K |
|
90
iShares S&P 100 ETF
OEF
$22.1B
| $2.41M | 0.21% |
8,355
| – | – |
|
91
Vanguard International High Dividend Yield ETF
VYMI
$11.7B
| $2.3M | 0.2% |
33,903
-321
| -0.9% | -$21.8K |
|
92
Skyworks Solutions
SWKS
$10.9B
| $2.26M | 0.19% |
25,437
| – | – |
|
93
Corteva
CTVA
$49.2B
| $2.25M | 0.19% |
39,416
-629
| -2% | -$35.8K |
|
94
Invesco Food & Beverage ETF
PBJ
$94.3M
| $2.12M | 0.18% |
45,681
-1,541
| -3% | -$71.6K |
|
95
Schwab US Broad Market ETF
SCHB
$36.1B
| $1.95M | 0.17% |
85,825
+57,620
| +204% | +$27.5K |
|
96
Adobe
ADBE
$148B
| $1.94M | 0.17% |
4,371
+15
| +0.3% | +$6.67K |
|
97
Merck
MRK
$210B
| $1.9M | 0.16% |
19,062
-1,045
| -5% | -$104K |
|
98
Paychex
PAYX
$48.8B
| $1.65M | 0.14% |
11,752
-2,346
| -17% | -$329K |
|
99
Lockheed Martin
LMT
$105B
| $1.62M | 0.14% |
3,340
+303
| +10% | +$147K |
|
100
Shell
SHEL
$211B
| $1.53M | 0.13% |
24,479
| – | – |
|